nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—CYP2D6—Niacin—atherosclerosis	0.142	0.3	CbGbCtD
Labetalol—CYP2D6—Simvastatin—atherosclerosis	0.113	0.237	CbGbCtD
Labetalol—CYP2D6—Pravastatin—atherosclerosis	0.11	0.232	CbGbCtD
Labetalol—CYP2D6—Lovastatin—atherosclerosis	0.11	0.232	CbGbCtD
Labetalol—Tingling sensation—Niacin—atherosclerosis	0.00343	0.00801	CcSEcCtD
Labetalol—Jaundice cholestatic—Simvastatin—atherosclerosis	0.00342	0.00798	CcSEcCtD
Labetalol—Numbness—Pravastatin—atherosclerosis	0.00328	0.00765	CcSEcCtD
Labetalol—Sleep disorder—Rosuvastatin—atherosclerosis	0.00318	0.00742	CcSEcCtD
Labetalol—Jaundice cholestatic—Niacin—atherosclerosis	0.00314	0.00733	CcSEcCtD
Labetalol—Sensory loss—Pravastatin—atherosclerosis	0.00314	0.00732	CcSEcCtD
Labetalol—Jaundice cholestatic—Pravastatin—atherosclerosis	0.00309	0.00721	CcSEcCtD
Labetalol—Amnesia—Rosuvastatin—atherosclerosis	0.00293	0.00683	CcSEcCtD
Labetalol—Nightmare—Simvastatin—atherosclerosis	0.0029	0.00677	CcSEcCtD
Labetalol—Nightmare—Pravastatin—atherosclerosis	0.00262	0.00612	CcSEcCtD
Labetalol—Sleep disorder—Simvastatin—atherosclerosis	0.00252	0.00588	CcSEcCtD
Labetalol—Amnesia—Lovastatin—atherosclerosis	0.00248	0.00579	CcSEcCtD
Labetalol—Amnesia—Ezetimibe—atherosclerosis	0.00244	0.00568	CcSEcCtD
Labetalol—Amnesia—Simvastatin—atherosclerosis	0.00232	0.00542	CcSEcCtD
Labetalol—Sleep disorder—Pravastatin—atherosclerosis	0.00228	0.00531	CcSEcCtD
Labetalol—Depression—Rosuvastatin—atherosclerosis	0.00212	0.00493	CcSEcCtD
Labetalol—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00211	0.00493	CcSEcCtD
Labetalol—Cramp muscle—Lovastatin—atherosclerosis	0.0021	0.0049	CcSEcCtD
Labetalol—Amnesia—Pravastatin—atherosclerosis	0.0021	0.0049	CcSEcCtD
Labetalol—Ifenprodil—HRH1—atherosclerosis	0.0021	0.191	CrCbGaD
Labetalol—Jaundice—Rosuvastatin—atherosclerosis	0.00207	0.00482	CcSEcCtD
Labetalol—Cramp muscle—Ezetimibe—atherosclerosis	0.00206	0.00481	CcSEcCtD
Labetalol—Cramp muscle—Simvastatin—atherosclerosis	0.00197	0.00458	CcSEcCtD
Labetalol—Affect lability—Pravastatin—atherosclerosis	0.00194	0.00453	CcSEcCtD
Labetalol—Urinary retention—Niacin—atherosclerosis	0.00191	0.00444	CcSEcCtD
Labetalol—Hepatitis—Rosuvastatin—atherosclerosis	0.0019	0.00444	CcSEcCtD
Labetalol—Mood swings—Pravastatin—atherosclerosis	0.00187	0.00436	CcSEcCtD
Labetalol—Erectile dysfunction—Lovastatin—atherosclerosis	0.00186	0.00433	CcSEcCtD
Labetalol—Liver function test abnormal—Niacin—atherosclerosis	0.00185	0.00431	CcSEcCtD
Labetalol—Orthostatic hypotension—Niacin—atherosclerosis	0.00183	0.00427	CcSEcCtD
Labetalol—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00182	0.00425	CcSEcCtD
Labetalol—Liver function test abnormal—Pravastatin—atherosclerosis	0.00182	0.00425	CcSEcCtD
Labetalol—Cramp muscle—Pravastatin—atherosclerosis	0.00178	0.00414	CcSEcCtD
Labetalol—Erectile dysfunction—Simvastatin—atherosclerosis	0.00174	0.00405	CcSEcCtD
Labetalol—Jaundice—Ezetimibe—atherosclerosis	0.00172	0.00401	CcSEcCtD
Labetalol—Angina pectoris—Niacin—atherosclerosis	0.00169	0.00393	CcSEcCtD
Labetalol—Depression—Simvastatin—atherosclerosis	0.00168	0.00391	CcSEcCtD
Labetalol—Mental disorder—Rosuvastatin—atherosclerosis	0.00167	0.00389	CcSEcCtD
Labetalol—Angina pectoris—Pravastatin—atherosclerosis	0.00166	0.00387	CcSEcCtD
Labetalol—Sweating increased—Pravastatin—atherosclerosis	0.00166	0.00387	CcSEcCtD
Labetalol—Jaundice—Simvastatin—atherosclerosis	0.00164	0.00382	CcSEcCtD
Labetalol—Hepatitis—Lovastatin—atherosclerosis	0.00161	0.00376	CcSEcCtD
Labetalol—Erectile dysfunction—Niacin—atherosclerosis	0.0016	0.00372	CcSEcCtD
Labetalol—Dysuria—Pravastatin—atherosclerosis	0.00159	0.00372	CcSEcCtD
Labetalol—Hepatitis—Ezetimibe—atherosclerosis	0.00158	0.00369	CcSEcCtD
Labetalol—Erectile dysfunction—Pravastatin—atherosclerosis	0.00157	0.00366	CcSEcCtD
Labetalol—Oedema peripheral—Ezetimibe—atherosclerosis	0.00156	0.00364	CcSEcCtD
Labetalol—Benazepril—MTHFR—atherosclerosis	0.00153	0.14	CrCbGaD
Labetalol—Depression—Pravastatin—atherosclerosis	0.00152	0.00354	CcSEcCtD
Labetalol—Angioedema—Rosuvastatin—atherosclerosis	0.00152	0.00353	CcSEcCtD
Labetalol—Hepatitis—Simvastatin—atherosclerosis	0.00151	0.00352	CcSEcCtD
Labetalol—Jaundice—Niacin—atherosclerosis	0.00151	0.00351	CcSEcCtD
Labetalol—Flushing—Lovastatin—atherosclerosis	0.0015	0.00349	CcSEcCtD
Labetalol—Jaundice—Pravastatin—atherosclerosis	0.00148	0.00346	CcSEcCtD
Labetalol—Sweating—Niacin—atherosclerosis	0.00148	0.00345	CcSEcCtD
Labetalol—Flushing—Ezetimibe—atherosclerosis	0.00147	0.00343	CcSEcCtD
Labetalol—Quinapril—ACE—atherosclerosis	0.00143	0.131	CrCbGaD
Labetalol—Alopecia—Lovastatin—atherosclerosis	0.00143	0.00333	CcSEcCtD
Labetalol—Flushing—Simvastatin—atherosclerosis	0.0014	0.00327	CcSEcCtD
Labetalol—Alopecia—Ezetimibe—atherosclerosis	0.0014	0.00326	CcSEcCtD
Labetalol—Mental disorder—Ezetimibe—atherosclerosis	0.00139	0.00323	CcSEcCtD
Labetalol—Hepatitis—Niacin—atherosclerosis	0.00139	0.00323	CcSEcCtD
Labetalol—Hypoaesthesia—Niacin—atherosclerosis	0.00138	0.00322	CcSEcCtD
Labetalol—Erythema—Ezetimibe—atherosclerosis	0.00138	0.00321	CcSEcCtD
Labetalol—Oedema peripheral—Niacin—atherosclerosis	0.00137	0.00318	CcSEcCtD
Labetalol—Hepatitis—Pravastatin—atherosclerosis	0.00137	0.00318	CcSEcCtD
Labetalol—Confusional state—Rosuvastatin—atherosclerosis	0.00136	0.00318	CcSEcCtD
Labetalol—Hypoaesthesia—Pravastatin—atherosclerosis	0.00136	0.00317	CcSEcCtD
Labetalol—Muscle spasms—Lovastatin—atherosclerosis	0.00135	0.00315	CcSEcCtD
Labetalol—Visual impairment—Niacin—atherosclerosis	0.00134	0.00312	CcSEcCtD
Labetalol—Alopecia—Simvastatin—atherosclerosis	0.00133	0.00311	CcSEcCtD
Labetalol—Muscle spasms—Ezetimibe—atherosclerosis	0.00133	0.00309	CcSEcCtD
Labetalol—Vision blurred—Lovastatin—atherosclerosis	0.00132	0.00309	CcSEcCtD
Labetalol—Mental disorder—Simvastatin—atherosclerosis	0.00132	0.00308	CcSEcCtD
Labetalol—Tremor—Lovastatin—atherosclerosis	0.00132	0.00307	CcSEcCtD
Labetalol—Visual impairment—Pravastatin—atherosclerosis	0.00132	0.00307	CcSEcCtD
Labetalol—Erythema—Simvastatin—atherosclerosis	0.00131	0.00306	CcSEcCtD
Labetalol—Ill-defined disorder—Lovastatin—atherosclerosis	0.0013	0.00304	CcSEcCtD
Labetalol—Flushing—Niacin—atherosclerosis	0.00129	0.003	CcSEcCtD
Labetalol—Angioedema—Lovastatin—atherosclerosis	0.00128	0.00299	CcSEcCtD
Labetalol—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00128	0.00298	CcSEcCtD
Labetalol—Malaise—Lovastatin—atherosclerosis	0.00127	0.00295	CcSEcCtD
Labetalol—Flushing—Pravastatin—atherosclerosis	0.00127	0.00295	CcSEcCtD
Labetalol—Muscle spasms—Simvastatin—atherosclerosis	0.00126	0.00295	CcSEcCtD
Labetalol—Vertigo—Lovastatin—atherosclerosis	0.00126	0.00294	CcSEcCtD
Labetalol—Angioedema—Ezetimibe—atherosclerosis	0.00126	0.00294	CcSEcCtD
Labetalol—Benazepril—ACE—atherosclerosis	0.00125	0.114	CrCbGaD
Labetalol—Malaise—Ezetimibe—atherosclerosis	0.00124	0.0029	CcSEcCtD
Labetalol—Vision blurred—Simvastatin—atherosclerosis	0.00124	0.00289	CcSEcCtD
Labetalol—Tremor—Simvastatin—atherosclerosis	0.00123	0.00287	CcSEcCtD
Labetalol—Alopecia—Niacin—atherosclerosis	0.00123	0.00286	CcSEcCtD
Labetalol—Ill-defined disorder—Simvastatin—atherosclerosis	0.00122	0.00284	CcSEcCtD
Labetalol—Palpitations—Ezetimibe—atherosclerosis	0.00122	0.00284	CcSEcCtD
Labetalol—Paraesthesia—Rosuvastatin—atherosclerosis	0.00122	0.00283	CcSEcCtD
Labetalol—Erythema—Niacin—atherosclerosis	0.00121	0.00281	CcSEcCtD
Labetalol—Alopecia—Pravastatin—atherosclerosis	0.00121	0.00281	CcSEcCtD
Labetalol—Angioedema—Simvastatin—atherosclerosis	0.0012	0.0028	CcSEcCtD
Labetalol—Dyspepsia—Rosuvastatin—atherosclerosis	0.00119	0.00278	CcSEcCtD
Labetalol—Hypertension—Ezetimibe—atherosclerosis	0.00119	0.00277	CcSEcCtD
Labetalol—Malaise—Simvastatin—atherosclerosis	0.00119	0.00276	CcSEcCtD
Labetalol—Discomfort—Lovastatin—atherosclerosis	0.00118	0.00276	CcSEcCtD
Labetalol—Vertigo—Simvastatin—atherosclerosis	0.00118	0.00275	CcSEcCtD
Labetalol—Muscle spasms—Niacin—atherosclerosis	0.00116	0.00271	CcSEcCtD
Labetalol—Discomfort—Ezetimibe—atherosclerosis	0.00116	0.0027	CcSEcCtD
Labetalol—Constipation—Rosuvastatin—atherosclerosis	0.00116	0.0027	CcSEcCtD
Labetalol—Pain—Rosuvastatin—atherosclerosis	0.00116	0.0027	CcSEcCtD
Labetalol—Confusional state—Lovastatin—atherosclerosis	0.00116	0.0027	CcSEcCtD
Labetalol—Anaphylactic shock—Lovastatin—atherosclerosis	0.00115	0.00267	CcSEcCtD
Labetalol—Muscle spasms—Pravastatin—atherosclerosis	0.00114	0.00266	CcSEcCtD
Labetalol—Vision blurred—Niacin—atherosclerosis	0.00114	0.00265	CcSEcCtD
Labetalol—Confusional state—Ezetimibe—atherosclerosis	0.00113	0.00264	CcSEcCtD
Labetalol—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00112	0.00262	CcSEcCtD
Labetalol—Vision blurred—Pravastatin—atherosclerosis	0.00112	0.00261	CcSEcCtD
Labetalol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00112	0.0026	CcSEcCtD
Labetalol—Tremor—Pravastatin—atherosclerosis	0.00111	0.0026	CcSEcCtD
Labetalol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00111	0.00258	CcSEcCtD
Labetalol—Discomfort—Simvastatin—atherosclerosis	0.00111	0.00258	CcSEcCtD
Labetalol—Angioedema—Niacin—atherosclerosis	0.0011	0.00257	CcSEcCtD
Labetalol—Ill-defined disorder—Pravastatin—atherosclerosis	0.0011	0.00257	CcSEcCtD
Labetalol—Angioedema—Pravastatin—atherosclerosis	0.00109	0.00253	CcSEcCtD
Labetalol—Vertigo—Niacin—atherosclerosis	0.00108	0.00253	CcSEcCtD
Labetalol—Syncope—Niacin—atherosclerosis	0.00108	0.00252	CcSEcCtD
Labetalol—Confusional state—Simvastatin—atherosclerosis	0.00108	0.00252	CcSEcCtD
Labetalol—Urticaria—Rosuvastatin—atherosclerosis	0.00108	0.00251	CcSEcCtD
Labetalol—Oedema—Simvastatin—atherosclerosis	0.00107	0.0025	CcSEcCtD
Labetalol—Anaphylactic shock—Simvastatin—atherosclerosis	0.00107	0.0025	CcSEcCtD
Labetalol—Malaise—Pravastatin—atherosclerosis	0.00107	0.0025	CcSEcCtD
Labetalol—Abdominal pain—Rosuvastatin—atherosclerosis	0.00107	0.00249	CcSEcCtD
Labetalol—Vertigo—Pravastatin—atherosclerosis	0.00107	0.00249	CcSEcCtD
Labetalol—Palpitations—Niacin—atherosclerosis	0.00107	0.00249	CcSEcCtD
Labetalol—Loss of consciousness—Niacin—atherosclerosis	0.00106	0.00247	CcSEcCtD
Labetalol—Ketoprofen—CXCL8—atherosclerosis	0.00105	0.0959	CrCbGaD
Labetalol—Paraesthesia—Lovastatin—atherosclerosis	0.00103	0.0024	CcSEcCtD
Labetalol—Hypertension—Pravastatin—atherosclerosis	0.00103	0.00239	CcSEcCtD
Labetalol—Dyspnoea—Lovastatin—atherosclerosis	0.00102	0.00238	CcSEcCtD
Labetalol—Paraesthesia—Ezetimibe—atherosclerosis	0.00101	0.00236	CcSEcCtD
Labetalol—Dyspepsia—Lovastatin—atherosclerosis	0.00101	0.00235	CcSEcCtD
Labetalol—Dyspnoea—Ezetimibe—atherosclerosis	0.001	0.00234	CcSEcCtD
Labetalol—Discomfort—Pravastatin—atherosclerosis	0.001	0.00233	CcSEcCtD
Labetalol—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000997	0.00232	CcSEcCtD
Labetalol—Dyspepsia—Ezetimibe—atherosclerosis	0.00099	0.00231	CcSEcCtD
Labetalol—Fatigue—Lovastatin—atherosclerosis	0.000989	0.00231	CcSEcCtD
Labetalol—Anaphylactic shock—Niacin—atherosclerosis	0.000985	0.0023	CcSEcCtD
Labetalol—Oedema—Niacin—atherosclerosis	0.000985	0.0023	CcSEcCtD
Labetalol—Pain—Lovastatin—atherosclerosis	0.000981	0.00229	CcSEcCtD
Labetalol—Constipation—Lovastatin—atherosclerosis	0.000981	0.00229	CcSEcCtD
Labetalol—Confusional state—Pravastatin—atherosclerosis	0.000978	0.00228	CcSEcCtD
Labetalol—Asthenia—Rosuvastatin—atherosclerosis	0.000971	0.00226	CcSEcCtD
Labetalol—Anaphylactic shock—Pravastatin—atherosclerosis	0.00097	0.00226	CcSEcCtD
Labetalol—Oedema—Pravastatin—atherosclerosis	0.00097	0.00226	CcSEcCtD
Labetalol—Fatigue—Ezetimibe—atherosclerosis	0.00097	0.00226	CcSEcCtD
Labetalol—Shock—Niacin—atherosclerosis	0.000969	0.00226	CcSEcCtD
Labetalol—Paraesthesia—Simvastatin—atherosclerosis	0.000963	0.00225	CcSEcCtD
Labetalol—Constipation—Ezetimibe—atherosclerosis	0.000962	0.00224	CcSEcCtD
Labetalol—Pain—Ezetimibe—atherosclerosis	0.000962	0.00224	CcSEcCtD
Labetalol—Pruritus—Rosuvastatin—atherosclerosis	0.000957	0.00223	CcSEcCtD
Labetalol—Dyspnoea—Simvastatin—atherosclerosis	0.000956	0.00223	CcSEcCtD
Labetalol—Hyperhidrosis—Niacin—atherosclerosis	0.000952	0.00222	CcSEcCtD
Labetalol—Feeling abnormal—Lovastatin—atherosclerosis	0.000945	0.0022	CcSEcCtD
Labetalol—Dyspepsia—Simvastatin—atherosclerosis	0.000944	0.0022	CcSEcCtD
Labetalol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000938	0.00219	CcSEcCtD
Labetalol—Hyperhidrosis—Pravastatin—atherosclerosis	0.000938	0.00219	CcSEcCtD
Labetalol—Feeling abnormal—Ezetimibe—atherosclerosis	0.000927	0.00216	CcSEcCtD
Labetalol—Diarrhoea—Rosuvastatin—atherosclerosis	0.000926	0.00216	CcSEcCtD
Labetalol—Fatigue—Simvastatin—atherosclerosis	0.000925	0.00216	CcSEcCtD
Labetalol—Hypotension—Niacin—atherosclerosis	0.00092	0.00215	CcSEcCtD
Labetalol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00092	0.00214	CcSEcCtD
Labetalol—Constipation—Simvastatin—atherosclerosis	0.000917	0.00214	CcSEcCtD
Labetalol—Pain—Simvastatin—atherosclerosis	0.000917	0.00214	CcSEcCtD
Labetalol—Urticaria—Lovastatin—atherosclerosis	0.000911	0.00212	CcSEcCtD
Labetalol—Body temperature increased—Lovastatin—atherosclerosis	0.000907	0.00211	CcSEcCtD
Labetalol—Abdominal pain—Lovastatin—atherosclerosis	0.000907	0.00211	CcSEcCtD
Labetalol—Dizziness—Rosuvastatin—atherosclerosis	0.000895	0.00209	CcSEcCtD
Labetalol—Urticaria—Ezetimibe—atherosclerosis	0.000894	0.00208	CcSEcCtD
Labetalol—Body temperature increased—Ezetimibe—atherosclerosis	0.000889	0.00207	CcSEcCtD
Labetalol—Abdominal pain—Ezetimibe—atherosclerosis	0.000889	0.00207	CcSEcCtD
Labetalol—Paraesthesia—Niacin—atherosclerosis	0.000884	0.00206	CcSEcCtD
Labetalol—Feeling abnormal—Simvastatin—atherosclerosis	0.000884	0.00206	CcSEcCtD
Labetalol—Dyspnoea—Niacin—atherosclerosis	0.000878	0.00205	CcSEcCtD
Labetalol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000877	0.00205	CcSEcCtD
Labetalol—Somnolence—Niacin—atherosclerosis	0.000876	0.00204	CcSEcCtD
Labetalol—Paraesthesia—Pravastatin—atherosclerosis	0.000871	0.00203	CcSEcCtD
Labetalol—Dyspepsia—Niacin—atherosclerosis	0.000867	0.00202	CcSEcCtD
Labetalol—Dyspnoea—Pravastatin—atherosclerosis	0.000865	0.00202	CcSEcCtD
Labetalol—Dyspepsia—Pravastatin—atherosclerosis	0.000854	0.00199	CcSEcCtD
Labetalol—Rash—Rosuvastatin—atherosclerosis	0.000853	0.00199	CcSEcCtD
Labetalol—Dermatitis—Rosuvastatin—atherosclerosis	0.000852	0.00199	CcSEcCtD
Labetalol—Urticaria—Simvastatin—atherosclerosis	0.000852	0.00199	CcSEcCtD
Labetalol—Body temperature increased—Simvastatin—atherosclerosis	0.000848	0.00198	CcSEcCtD
Labetalol—Abdominal pain—Simvastatin—atherosclerosis	0.000848	0.00198	CcSEcCtD
Labetalol—Headache—Rosuvastatin—atherosclerosis	0.000848	0.00198	CcSEcCtD
Labetalol—Hypersensitivity—Lovastatin—atherosclerosis	0.000845	0.00197	CcSEcCtD
Labetalol—Pain—Niacin—atherosclerosis	0.000842	0.00196	CcSEcCtD
Labetalol—Fatigue—Pravastatin—atherosclerosis	0.000836	0.00195	CcSEcCtD
Labetalol—Pain—Pravastatin—atherosclerosis	0.000829	0.00193	CcSEcCtD
Labetalol—Constipation—Pravastatin—atherosclerosis	0.000829	0.00193	CcSEcCtD
Labetalol—Hypersensitivity—Ezetimibe—atherosclerosis	0.000829	0.00193	CcSEcCtD
Labetalol—Asthenia—Lovastatin—atherosclerosis	0.000823	0.00192	CcSEcCtD
Labetalol—Pruritus—Lovastatin—atherosclerosis	0.000811	0.00189	CcSEcCtD
Labetalol—Asthenia—Ezetimibe—atherosclerosis	0.000807	0.00188	CcSEcCtD
Labetalol—Gastrointestinal pain—Niacin—atherosclerosis	0.000805	0.00188	CcSEcCtD
Labetalol—Nausea—Rosuvastatin—atherosclerosis	0.000804	0.00187	CcSEcCtD
Labetalol—Feeling abnormal—Pravastatin—atherosclerosis	0.000799	0.00186	CcSEcCtD
Labetalol—Pruritus—Ezetimibe—atherosclerosis	0.000796	0.00186	CcSEcCtD
Labetalol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000793	0.00185	CcSEcCtD
Labetalol—Hypersensitivity—Simvastatin—atherosclerosis	0.00079	0.00184	CcSEcCtD
Labetalol—Diarrhoea—Lovastatin—atherosclerosis	0.000785	0.00183	CcSEcCtD
Labetalol—Urticaria—Niacin—atherosclerosis	0.000783	0.00182	CcSEcCtD
Labetalol—Body temperature increased—Niacin—atherosclerosis	0.000779	0.00182	CcSEcCtD
Labetalol—Abdominal pain—Niacin—atherosclerosis	0.000779	0.00182	CcSEcCtD
Labetalol—Mirabegron—ALB—atherosclerosis	0.000775	0.0707	CrCbGaD
Labetalol—Urticaria—Pravastatin—atherosclerosis	0.00077	0.0018	CcSEcCtD
Labetalol—Asthenia—Simvastatin—atherosclerosis	0.00077	0.00179	CcSEcCtD
Labetalol—Diarrhoea—Ezetimibe—atherosclerosis	0.00077	0.00179	CcSEcCtD
Labetalol—Abdominal pain—Pravastatin—atherosclerosis	0.000767	0.00179	CcSEcCtD
Labetalol—Body temperature increased—Pravastatin—atherosclerosis	0.000767	0.00179	CcSEcCtD
Labetalol—Pruritus—Simvastatin—atherosclerosis	0.000759	0.00177	CcSEcCtD
Labetalol—Dizziness—Lovastatin—atherosclerosis	0.000758	0.00177	CcSEcCtD
Labetalol—Dizziness—Ezetimibe—atherosclerosis	0.000744	0.00173	CcSEcCtD
Labetalol—Diarrhoea—Simvastatin—atherosclerosis	0.000734	0.00171	CcSEcCtD
Labetalol—Vomiting—Lovastatin—atherosclerosis	0.000729	0.0017	CcSEcCtD
Labetalol—Hypersensitivity—Niacin—atherosclerosis	0.000726	0.00169	CcSEcCtD
Labetalol—Rash—Lovastatin—atherosclerosis	0.000723	0.00169	CcSEcCtD
Labetalol—Dermatitis—Lovastatin—atherosclerosis	0.000722	0.00168	CcSEcCtD
Labetalol—Headache—Lovastatin—atherosclerosis	0.000718	0.00168	CcSEcCtD
Labetalol—Vomiting—Ezetimibe—atherosclerosis	0.000715	0.00167	CcSEcCtD
Labetalol—Hypersensitivity—Pravastatin—atherosclerosis	0.000715	0.00167	CcSEcCtD
Labetalol—Dizziness—Simvastatin—atherosclerosis	0.000709	0.00165	CcSEcCtD
Labetalol—Rash—Ezetimibe—atherosclerosis	0.000709	0.00165	CcSEcCtD
Labetalol—Dermatitis—Ezetimibe—atherosclerosis	0.000709	0.00165	CcSEcCtD
Labetalol—Asthenia—Niacin—atherosclerosis	0.000707	0.00165	CcSEcCtD
Labetalol—Headache—Ezetimibe—atherosclerosis	0.000705	0.00164	CcSEcCtD
Labetalol—Pruritus—Niacin—atherosclerosis	0.000697	0.00162	CcSEcCtD
Labetalol—Asthenia—Pravastatin—atherosclerosis	0.000696	0.00162	CcSEcCtD
Labetalol—Pruritus—Pravastatin—atherosclerosis	0.000686	0.0016	CcSEcCtD
Labetalol—Vomiting—Simvastatin—atherosclerosis	0.000682	0.00159	CcSEcCtD
Labetalol—Nausea—Lovastatin—atherosclerosis	0.000681	0.00159	CcSEcCtD
Labetalol—Rash—Simvastatin—atherosclerosis	0.000676	0.00158	CcSEcCtD
Labetalol—Dermatitis—Simvastatin—atherosclerosis	0.000676	0.00158	CcSEcCtD
Labetalol—Diarrhoea—Niacin—atherosclerosis	0.000674	0.00157	CcSEcCtD
Labetalol—Headache—Simvastatin—atherosclerosis	0.000672	0.00157	CcSEcCtD
Labetalol—Nausea—Ezetimibe—atherosclerosis	0.000668	0.00156	CcSEcCtD
Labetalol—Diarrhoea—Pravastatin—atherosclerosis	0.000664	0.00155	CcSEcCtD
Labetalol—Dizziness—Niacin—atherosclerosis	0.000651	0.00152	CcSEcCtD
Labetalol—Dizziness—Pravastatin—atherosclerosis	0.000641	0.0015	CcSEcCtD
Labetalol—Nausea—Simvastatin—atherosclerosis	0.000637	0.00149	CcSEcCtD
Labetalol—Salsalate—PTGS2—atherosclerosis	0.000629	0.0574	CrCbGaD
Labetalol—Vomiting—Niacin—atherosclerosis	0.000626	0.00146	CcSEcCtD
Labetalol—Rash—Niacin—atherosclerosis	0.000621	0.00145	CcSEcCtD
Labetalol—Dermatitis—Niacin—atherosclerosis	0.00062	0.00145	CcSEcCtD
Labetalol—Headache—Niacin—atherosclerosis	0.000617	0.00144	CcSEcCtD
Labetalol—Vomiting—Pravastatin—atherosclerosis	0.000617	0.00144	CcSEcCtD
Labetalol—Rash—Pravastatin—atherosclerosis	0.000612	0.00143	CcSEcCtD
Labetalol—Dermatitis—Pravastatin—atherosclerosis	0.000611	0.00142	CcSEcCtD
Labetalol—Headache—Pravastatin—atherosclerosis	0.000608	0.00142	CcSEcCtD
Labetalol—Nausea—Niacin—atherosclerosis	0.000585	0.00136	CcSEcCtD
Labetalol—Nausea—Pravastatin—atherosclerosis	0.000576	0.00134	CcSEcCtD
Labetalol—Fenoprofen—PTGS2—atherosclerosis	0.00052	0.0474	CrCbGaD
Labetalol—Fenoprofen—ALB—atherosclerosis	0.000463	0.0422	CrCbGaD
Labetalol—Flurbiprofen—PTGS2—atherosclerosis	0.000339	0.0309	CrCbGaD
Labetalol—Ketoprofen—PTGS2—atherosclerosis	0.000307	0.028	CrCbGaD
Labetalol—Flurbiprofen—ALB—atherosclerosis	0.000302	0.0276	CrCbGaD
Labetalol—Ketoprofen—ALB—atherosclerosis	0.000273	0.0249	CrCbGaD
Labetalol—ADRB1—Signaling Pathways—CCL4—atherosclerosis	7.3e-05	0.000861	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—GHRL—atherosclerosis	7.28e-05	0.000858	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—KNG1—atherosclerosis	7.19e-05	0.000848	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	7.17e-05	0.000846	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AGTR1—atherosclerosis	7.15e-05	0.000843	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL4—atherosclerosis	7.14e-05	0.000842	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—F2—atherosclerosis	7.11e-05	0.000838	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	7.03e-05	0.000829	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	6.99e-05	0.000825	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOA2—atherosclerosis	6.82e-05	0.000804	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PIK3CG—atherosclerosis	6.8e-05	0.000802	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOA2—atherosclerosis	6.67e-05	0.000787	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—KNG1—atherosclerosis	6.53e-05	0.00077	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—UTS2—atherosclerosis	6.5e-05	0.000767	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—KNG1—atherosclerosis	6.5e-05	0.000766	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AGTR1—atherosclerosis	6.49e-05	0.000765	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AGTR1—atherosclerosis	6.46e-05	0.000762	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	6.39e-05	0.000753	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—UTS2—atherosclerosis	6.36e-05	0.00075	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LTA4H—atherosclerosis	6.36e-05	0.00075	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCG8—atherosclerosis	6.36e-05	0.00075	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	6.35e-05	0.000749	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCL2—atherosclerosis	6.34e-05	0.000747	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PLG—atherosclerosis	6.29e-05	0.000742	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CX3CR1—atherosclerosis	6.24e-05	0.000736	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CASR—atherosclerosis	6.24e-05	0.000736	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CX3CL1—atherosclerosis	6.12e-05	0.000721	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	6.1e-05	0.00072	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CASR—atherosclerosis	6.1e-05	0.00072	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—EDN1—atherosclerosis	6.06e-05	0.000715	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CCL5—atherosclerosis	6.01e-05	0.000709	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	5.98e-05	0.000706	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SOCS3—atherosclerosis	5.96e-05	0.000703	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	5.93e-05	0.000699	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	5.88e-05	0.000694	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CNR2—atherosclerosis	5.8e-05	0.000684	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	5.79e-05	0.000683	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	5.78e-05	0.000682	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MMP3—atherosclerosis	5.76e-05	0.000679	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF2—atherosclerosis	5.73e-05	0.000676	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	5.72e-05	0.000674	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	5.67e-05	0.000669	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	5.67e-05	0.000668	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	5.66e-05	0.000667	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	5.59e-05	0.000659	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOB—atherosclerosis	5.56e-05	0.000656	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CXCL8—atherosclerosis	5.52e-05	0.000651	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	5.5e-05	0.000649	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EDN1—atherosclerosis	5.48e-05	0.000646	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	5.46e-05	0.000644	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL5—atherosclerosis	5.43e-05	0.000641	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	5.38e-05	0.000635	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	5.34e-05	0.00063	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—LPL—atherosclerosis	5.31e-05	0.000627	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	5.19e-05	0.000612	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—VWF—atherosclerosis	5.17e-05	0.000609	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PRKCG—atherosclerosis	5.17e-05	0.000609	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	5.14e-05	0.000606	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	5.1e-05	0.000602	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	5.08e-05	0.000599	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—VWF—atherosclerosis	5.05e-05	0.000596	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SPP1—atherosclerosis	5.03e-05	0.000593	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	5.03e-05	0.000593	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCG1—atherosclerosis	5.03e-05	0.000593	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	5.02e-05	0.000593	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CXCL8—atherosclerosis	5.01e-05	0.000591	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	4.99e-05	0.000589	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	4.99e-05	0.000588	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	4.92e-05	0.00058	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	4.88e-05	0.000575	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	4.77e-05	0.000563	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—FABP4—atherosclerosis	4.73e-05	0.000558	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LCAT—atherosclerosis	4.73e-05	0.000558	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	4.67e-05	0.000551	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PDGFB—atherosclerosis	4.66e-05	0.000549	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	4.65e-05	0.000548	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOA4—atherosclerosis	4.64e-05	0.000547	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	4.57e-05	0.000539	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP7A1—atherosclerosis	4.56e-05	0.000538	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	4.55e-05	0.000536	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AGT—atherosclerosis	4.55e-05	0.000536	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	4.51e-05	0.000532	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	4.51e-05	0.000532	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	4.49e-05	0.000529	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	4.47e-05	0.000527	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—LEP—atherosclerosis	4.45e-05	0.000525	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOE—atherosclerosis	4.45e-05	0.000525	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	4.45e-05	0.000524	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CAV1—atherosclerosis	4.41e-05	0.00052	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	4.41e-05	0.00052	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	4.41e-05	0.00052	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOA1—atherosclerosis	4.4e-05	0.000519	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	4.39e-05	0.000518	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	4.39e-05	0.000518	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	4.39e-05	0.000518	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	4.39e-05	0.000518	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	4.35e-05	0.000513	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	4.3e-05	0.000507	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	4.3e-05	0.000507	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	4.3e-05	0.000507	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ESR1—atherosclerosis	4.25e-05	0.000501	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—F2—atherosclerosis	4.22e-05	0.000498	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP27A1—atherosclerosis	4.21e-05	0.000497	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—F2—atherosclerosis	4.2e-05	0.000495	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—F2—atherosclerosis	4.13e-05	0.000487	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	4.04e-05	0.000476	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CG—atherosclerosis	4.02e-05	0.000474	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOA2—atherosclerosis	3.99e-05	0.000471	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	3.99e-05	0.000471	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	3.99e-05	0.000471	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALOX15—atherosclerosis	3.99e-05	0.000471	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	3.95e-05	0.000466	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCG5—atherosclerosis	3.95e-05	0.000465	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	3.86e-05	0.000455	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—MAPK3—atherosclerosis	3.85e-05	0.000454	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	3.83e-05	0.000452	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LPA—atherosclerosis	3.81e-05	0.000449	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—INS—atherosclerosis	3.8e-05	0.000449	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	3.77e-05	0.000445	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	3.76e-05	0.000444	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	3.75e-05	0.000442	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL2—atherosclerosis	3.74e-05	0.000441	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PLG—atherosclerosis	3.74e-05	0.000441	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—BGN—atherosclerosis	3.69e-05	0.000435	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF1—atherosclerosis	3.68e-05	0.000434	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	3.68e-05	0.000434	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PLG—atherosclerosis	3.65e-05	0.000431	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOA5—atherosclerosis	3.65e-05	0.000431	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	3.54e-05	0.000417	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	3.52e-05	0.000415	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SERPINE1—atherosclerosis	3.49e-05	0.000412	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	3.46e-05	0.000408	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	3.42e-05	0.000403	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	3.4e-05	0.000401	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALOX5—atherosclerosis	3.4e-05	0.000401	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	3.34e-05	0.000394	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NOS3—atherosclerosis	3.34e-05	0.000393	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	3.33e-05	0.000392	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOB—atherosclerosis	3.3e-05	0.00039	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	3.27e-05	0.000386	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	3.25e-05	0.000383	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOB—atherosclerosis	3.23e-05	0.000381	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	3.22e-05	0.00038	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	3.2e-05	0.000378	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	3.18e-05	0.000375	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	3.15e-05	0.000372	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LPL—atherosclerosis	3.15e-05	0.000372	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LPL—atherosclerosis	3.08e-05	0.000364	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	3.07e-05	0.000362	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NAMPT—atherosclerosis	3.05e-05	0.000359	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LIPC—atherosclerosis	3.03e-05	0.000357	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOC3—atherosclerosis	3.01e-05	0.000355	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	3e-05	0.000354	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LDLR—atherosclerosis	2.99e-05	0.000353	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	2.99e-05	0.000352	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	2.97e-05	0.000351	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCL8—atherosclerosis	2.96e-05	0.000349	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	2.92e-05	0.000345	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CETP—atherosclerosis	2.92e-05	0.000344	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	2.91e-05	0.000343	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—AKT1—atherosclerosis	2.86e-05	0.000337	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6—atherosclerosis	2.81e-05	0.000332	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SCARB1—atherosclerosis	2.8e-05	0.00033	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	2.76e-05	0.000326	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	2.7e-05	0.000319	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGT—atherosclerosis	2.7e-05	0.000318	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MMP9—atherosclerosis	2.68e-05	0.000316	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NFKB1—atherosclerosis	2.65e-05	0.000312	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LEP—atherosclerosis	2.64e-05	0.000312	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOE—atherosclerosis	2.64e-05	0.000312	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HMGCR—atherosclerosis	2.64e-05	0.000312	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGT—atherosclerosis	2.64e-05	0.000311	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	2.62e-05	0.000309	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	2.61e-05	0.000308	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAPK8—atherosclerosis	2.6e-05	0.000307	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AKT1—atherosclerosis	2.6e-05	0.000306	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LEP—atherosclerosis	2.59e-05	0.000305	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOE—atherosclerosis	2.59e-05	0.000305	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	2.56e-05	0.000302	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	2.56e-05	0.000301	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	2.52e-05	0.000298	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—F2—atherosclerosis	2.49e-05	0.000294	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	2.47e-05	0.000291	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—F2—atherosclerosis	2.44e-05	0.000288	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—VEGFA—atherosclerosis	2.4e-05	0.000283	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	2.39e-05	0.000281	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—STAT3—atherosclerosis	2.38e-05	0.000281	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCA1—atherosclerosis	2.35e-05	0.000278	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	2.33e-05	0.000275	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	2.28e-05	0.000269	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAPK3—atherosclerosis	2.27e-05	0.000268	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—INS—atherosclerosis	2.26e-05	0.000266	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	2.23e-05	0.000264	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	2.22e-05	0.000262	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—INS—atherosclerosis	2.21e-05	0.000261	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TGFB1—atherosclerosis	2.21e-05	0.00026	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	2.18e-05	0.000258	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	2.17e-05	0.000256	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	2.14e-05	0.000252	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	2.07e-05	0.000245	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	2.03e-05	0.000239	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HMOX1—atherosclerosis	2.02e-05	0.000238	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	1.98e-05	0.000234	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	1.94e-05	0.000228	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOB—atherosclerosis	1.93e-05	0.000228	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.88e-05	0.000222	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LPL—atherosclerosis	1.85e-05	0.000218	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GPX1—atherosclerosis	1.8e-05	0.000213	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	1.76e-05	0.000207	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CD36—atherosclerosis	1.76e-05	0.000207	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	1.72e-05	0.000203	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	1.7e-05	0.0002	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	1.67e-05	0.000197	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.66e-05	0.000196	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6—atherosclerosis	1.66e-05	0.000196	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	1.66e-05	0.000196	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	1.63e-05	0.000193	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARA—atherosclerosis	1.63e-05	0.000192	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	1.59e-05	0.000187	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AGT—atherosclerosis	1.58e-05	0.000186	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	1.57e-05	0.000185	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	1.55e-05	0.000183	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOE—atherosclerosis	1.55e-05	0.000183	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	1.55e-05	0.000182	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	1.54e-05	0.000182	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	1.54e-05	0.000181	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CAV1—atherosclerosis	1.53e-05	0.000181	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AKT1—atherosclerosis	1.53e-05	0.000181	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOA1—atherosclerosis	1.53e-05	0.000181	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	1.51e-05	0.000178	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	1.51e-05	0.000178	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	1.43e-05	0.000168	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	1.41e-05	0.000167	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.4e-05	0.000165	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	1.4e-05	0.000165	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	1.38e-05	0.000163	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	1.35e-05	0.000159	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARG—atherosclerosis	1.35e-05	0.000159	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—INS—atherosclerosis	1.32e-05	0.000156	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	1.32e-05	0.000156	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	1.31e-05	0.000154	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	1.28e-05	0.000151	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALB—atherosclerosis	1.21e-05	0.000143	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NOS3—atherosclerosis	1.16e-05	0.000137	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.06e-05	0.000125	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6—atherosclerosis	9.87e-06	0.000116	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6—atherosclerosis	9.65e-06	0.000114	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	9.1e-06	0.000107	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	8.9e-06	0.000105	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AKT1—atherosclerosis	5.33e-06	6.29e-05	CbGpPWpGaD
